2 completed, 1 not yet recruiting. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Completed 2, Not yet recruiting 1 |
Follow naoxintong: new trials by email Literature Review of naoxintong trials Research Report on naoxintong
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Naoxintong Capsule for Diabetic Nephropathy With Dampness Retention Pattern: A Multicenter, Randomized, Double-Blind, Placebo-Controlled TrialAcronymNXT-DKD Naoxintong Capsule, Placebo - Diabetic Nephropathy | Phase 4 | Not yet recruiting | Chen Xiangmei | 410 | 2027-03-01 | 2026-07-13 |
| Curative Efficacy of Secondary Prevention for Patients With Ischemic Stroke Through Syndrome Differentiation of TCM Naoxintong Capsule, Placebo - Ischemic Stroke | Phase 4 | Completed | Xiaofei Yu | 2200 | 2016-04-01 | 2018-11-19 |
| Efficacy and Safety of Qizhitongluo Capsule in the Recovery Phase of Ischemic Stroke Qizhitongluo Capsule, Naoxintong Capsule, Aspirin Enteric-coated Tablets - Ischemic Stroke | Phase 4 | Completed | China Academy of Chinese Medical Sciences | 622 | 2013-10-01 | 2016-10-12 |
Ischemic Stroke (2) · Diabetic Nephropathies (1)
Chen Xiangmei (1) · China Academy of Chinese Medical Sciences (1) · Xiaofei Yu (1)
China (3)
Xiao F Yu, Doctor (1) · Yingzhen Xie, M.D. (1) · Zhong Wang, Ph.D. (1)
PMID 11786451, PMID 16176495, PMID 17437989, PMID 18757238, PMID 21125042, PMID 21502757, PMID 25394855, PMID 25401325, PMID 36251140